Democrats dig in on health care as threat of government shutdown looms

Democrats dig in on health care as threat of government shutdown looms


U.S. Senate Minority Leader Chuck Schumer (D-NY) speaks to reporters as Senate Democratic leaders hold a press conference following their weekly policy lunch on Capitol Hill in Washington, D.C., U.S., Sept. 9, 2025.

Elizabeth Frantz | Reuters

Congressional Democrats are zeroing in on health care as a key sticking point in negotiations with the threat of a government shutdown looming.

Senate Democratic Leader Chuck Schumer and House Democratic Leader Hakeem Jeffries, both of New York, have said that they will not support GOP-backed legislation to keep the government funded unless it includes certain health-care provisions, setting up a bitter policy fight with GOP lawmakers that could trigger a shutdown.

“We have made clear that under no circumstances will we support a partisan Republican spending bill that continues to rip away health care from the American people,” Jeffries said on the House floor this week.

With funding on the brink, congressional Democrats are demanding that any legislation that would avert a shutdown include an extension of the Affordable Care Act tax credits, which are set to expire at the end of this year unless Congress intervenes.

If the tax credits disappear, average premiums could soar by about 75%, according to KFF, a nonpartisan health policy research group.

The vast majority of Americans with a health plan from the ACA marketplace had a premium tax credit in 2025, according to KFF, meaning their elimination would have widespread consequences.

Democrats have also repeatedly criticized the cuts to Medicaid that were part of the “One, Big Beautiful Bill,” and they want Republicans to reverse them.

Read more CNBC politics coverage

With Democrats appearing to hold firm, their new hard line will complicate negotiations ahead of Sept. 30, which is when government funding is currently set to expire.

A unified House Republican conference could pass legislation without Democratic support, but Senate Republicans need some Democratic support, given their razor-thin majority.

In March, Schumer joined Republicans to avert a government shutdown, but his move drew sharp criticism from his party.

This time, with an eye on the 2026 midterm elections, Schumer and his Democratic colleagues have signaled that they will not support government funding legislation that does not include the key concessions.

But Republicans, for their part, also appear unlikely to budge on the Democratic lawmakers’ requests.

President Donald Trump dismissed Democrats’ demands, telling Fox News this week that “there is something wrong with them.”

“If you gave them every dream right now … they want to give away money to this or that and destroy the country. If you gave them every dream, they would not vote for it,” Trump said on “Fox and Friends.”

Senate Majority Leader John Thune, R-S.D., also accused Democrats of “clamoring” for a government shutdown.

“They want a fight with the Trump administration,” Thune told Punchbowl News’ “Fly Out Day.”

“But they don’t have a good reason to do it. And I don’t intend to give them a good reason to do it,” he continued.

With time ticking, lawmakers are likely to pursue a stopgap measure to keep funding stable at federal agencies.

But even reaching that temporary solution will be an uphill battle.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More